{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T19:08:50Z","timestamp":1788548930284,"version":"build-2803163510"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:00:00Z","timestamp":1769212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:00:00Z","timestamp":1769212800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Kunshan Traditional Chinese Medicine Science and Technology Development Fund Project","award":["KZYY2209"],"award-info":[{"award-number":["KZYY2209"]}]},{"name":"Nanjing University of Chinese Medicine Natural Science Foundation Project","award":["XZR2024193"],"award-info":[{"award-number":["XZR2024193"]}]},{"name":"Kunshan Social Development Project","award":["KS2233"],"award-info":[{"award-number":["KS2233"]}]},{"name":"Key Projects of Jiangsu Provincial Science","award":["ZD202425"],"award-info":[{"award-number":["ZD202425"]}]},{"name":"Suzhou Clinical Key Disease Diagnosis and Treatment Project","award":["LCZX202229"],"award-info":[{"award-number":["LCZX202229"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Non-alcoholic fatty liver disease (NAFLD), often accompanied by insulin resistance, obesity, and hyperlipidemia, is a challenging metabolic disorder to treat. Ge-Lian Qi-Shen Decoction, a traditional Chinese herbal formula, has been clinically used to alleviate symptoms associated with NAFLD, but its underlying mechanisms remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A NAFLD model was established in C57BL\/6J mice using a high-fat diet (HFD). The effects of 4-week GQD intervention at different doses on NAFLD-related symptoms were assessed using biochemical analyses, pathological sections, and oral glucose tolerance tests. ELISA and qPCR were employed to investigate the impact of GQD on serum GLP-1 levels and intestinal\n                      <jats:italic>Gcg<\/jats:italic>\n                      gene expression in NAFLD mice. The direct stimulatory effects of GQD on GLP-1 secretion were examined in NCI-H716 cells and HFD-fed mice. UPLC-MS\/MS was used to analyze the composition of ileal contents in GQD-treated mice, and the regulatory effects of 24 identified compounds on GLP-1 secretion were evaluated. Additionally, 16S rDNA sequencing, metabolomics and fecal microbiota transplantation were utilized to explore the role of gut microbiota in GQD\u2019s anti-NAFLD effect.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      GQD improved HFD-induced hepatic steatosis, impaired glucose tolerance, and elevated blood lipid levels in a dose-dependent manner. It increased serum GLP-1 levels, reduced energy intake, and enhanced glucose tolerance in mice. A single dose of GQD directly elevated serum GLP-1 levels in HFD-fed mice and improved glucose tolerance in a GLP-1-dependent manner. In NCI-H716 cells, GQD promoted intracellular calcium influx and GLP-1 release by activating two G-protein-coupled receptors (GPCRs): bitter taste receptors and TGR5. Compounds such as berberine, coptisine, nuciferine, liensinine, higenamine, aurantio-obtusin, and obtusifolin in GQD activated bitter taste receptors, while maslinic acid and cycloastragenol activated TGR5, facilitating GLP-1 secretion. Furthermore, GQD gavage increased the levels of\n                      <jats:italic>Muribaculaceae<\/jats:italic>\n                      and\n                      <jats:italic>Akkermansia<\/jats:italic>\n                      in mouse feces, leading to elevated concentrations of short-chain fatty acids (SCFAs) such as acetate, propionate, butyrate, and valerate. These SCFAs potentially activated fatty acid-related GPCRs, such as GPR41, in the colon, thereby enhancing colonic\n                      <jats:italic>Gcg<\/jats:italic>\n                      expression. FMT experiment showed that gut microbiota can partially mediate the effect of GQD in increasing GLP-1 levels thus alleviating NAFLD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Some alkaloids, anthraquinones, and triterpenoids in GQD can activate GPCRs, including bitter taste receptors and TGR5, in intestinal endocrine cells, promoting GLP-1 secretion. Simultaneously, GQD regulates gut microbiota composition and metabolism, increasing SCFA levels and\n                      <jats:italic>Gcg<\/jats:italic>\n                      gene expression, leading to sustained elevation of GLP-1 levels. These combined effects contribute to the alleviation of NAFLD symptoms.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13020-025-01305-9","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T05:51:56Z","timestamp":1769233916000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Targeting G-protein-coupled receptors and gut microbiota: Ge-Lian Qi-Shen decoction elevates GLP-1 to combat non-alcoholic fatty liver disease"],"prefix":"10.1186","volume":"21","author":[{"given":"Menglei","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xionglin","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zichen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zepeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manman","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruimin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjun","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiping","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,24]]},"reference":[{"issue":"9","key":"1305_CR1","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi K, Azhari H, Charette JH, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022;7(9):851\u201361.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"1305_CR2","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jhep.2020.03.006","volume":"73","author":"Z Liu","year":"2020","unstructured":"Liu Z, Zhang Y, Graham S, et al. Causal relationships between NAFLD, T2D and obesity have implications for disease subphenotyping. J Hepatol. 2020;73(2):263\u201376.","journal-title":"J Hepatol"},{"issue":"10","key":"1305_CR3","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","volume":"184","author":"R Loomba","year":"2021","unstructured":"Loomba R, Friedman SL, Shulman GI. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell. 2021;184(10):2537\u201364.","journal-title":"Cell"},{"key":"1305_CR4","first-page":"494","volume":"07","author":"JG Sun","year":"2003","unstructured":"Sun JG, Wu JF, Yang J, et al. Clinical observation on 100 cases of fatty liver treated with Jiang Zhi Mai An and rhubarb umbilical cord compress. Hebei Tradit Chin Med. 2003;07:494\u20136.","journal-title":"Hebei Tradit Chin Med"},{"issue":"05","key":"1305_CR5","first-page":"32","volume":"46","author":"H Peng","year":"2014","unstructured":"Peng H, Yang J, Wu J, et al. Clinical Study on Jiangzhi Mai\u2019an granules in treating 40 cases of non-alcoholic fatty liver disease. Jiangsu J Tradit Chin Med. 2014;46(05):32\u20133.","journal-title":"Jiangsu J Tradit Chin Med"},{"key":"1305_CR6","first-page":"14","volume":"12","author":"J Yang","year":"2001","unstructured":"Yang J, Sun JG, Xu ZH. Treatment of fatty liver with Jiang Zhi Mai An in 52 cases. J Pract Chin Med. 2001;12:14\u20135.","journal-title":"J Pract Chin Med"},{"key":"1305_CR7","doi-asserted-by":"publisher","first-page":"120197","DOI":"10.1016\/j.carbpol.2022.120197","volume":"299","author":"Q Li","year":"2023","unstructured":"Li Q, Liu W, Zhang H, et al. \u03b1-D-1,3-glucan from Radix Puerariae thomsonii improves NAFLD by regulating the intestinal flora and metabolites. Carbohydr Polym. 2023;299:120197.","journal-title":"Carbohydr Polym"},{"key":"1305_CR8","doi-asserted-by":"publisher","first-page":"108593","DOI":"10.1016\/j.pharmthera.2024.108593","volume":"254","author":"X Lin","year":"2024","unstructured":"Lin X, Zhang J, Chu Y, et al. Berberine prevents NAFLD and HCC by modulating metabolic disorders. Pharmacol Ther. 2024;254:108593.","journal-title":"Pharmacol Ther"},{"key":"1305_CR9","doi-asserted-by":"publisher","first-page":"118662","DOI":"10.1016\/j.jep.2024.118662","volume":"335","author":"L Zheng","year":"2024","unstructured":"Zheng L, Li B, Yuan A, et al. TFEB activator tanshinone IIA and derivatives derived from Salvia miltiorrhiza Bge. attenuate hepatic steatosis and insulin resistance. J Ethnopharmacol. 2024;335:118662.","journal-title":"J Ethnopharmacol"},{"issue":"6","key":"1305_CR10","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1016\/j.apsb.2021.12.012","volume":"12","author":"X Du","year":"2022","unstructured":"Du X, Di Malta C, Fang Z, et al. Nuciferine protects against high-fat diet-induced hepatic steatosis and insulin resistance via activating TFEB-mediated autophagy-lysosomal pathway. Acta Pharm Sin B. 2022;12(6):2869\u201386.","journal-title":"Acta Pharm Sin B"},{"issue":"13","key":"1305_CR11","doi-asserted-by":"publisher","first-page":"7287","DOI":"10.1039\/D2FO01009G","volume":"13","author":"M Zhong","year":"2022","unstructured":"Zhong M, Yan Y, Yuan H, et al. Astragalus mongholicus polysaccharides ameliorate hepatic lipid accumulation and inflammation as well as modulate gut microbiota in NAFLD rats. Food Funct. 2022;13(13):7287\u2013301.","journal-title":"Food Funct"},{"issue":"8","key":"1305_CR12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/ddr.21461","volume":"79","author":"A Nair","year":"2018","unstructured":"Nair A, Morsy MA, Jacob S. Dose translation between laboratory animals and human in preclinical and clinical phases of drug development. Drug Dev Res. 2018;79(8):373\u201382.","journal-title":"Drug Dev Res"},{"key":"1305_CR13","first-page":"56672","volume":"131","author":"C Nagy","year":"2018","unstructured":"Nagy C, Einwallner E. Study of in vivo glucose metabolism in high-fat diet-fed mice using oral glucose tolerance test (OGTT) and insulin tolerance test (ITT). J Vis Exp JoVE. 2018;131:56672.","journal-title":"J Vis Exp JoVE"},{"issue":"9","key":"1305_CR14","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/s41419-020-02974-0","volume":"11","author":"Z Xie","year":"2020","unstructured":"Xie Z, Jiang H, Liu W, et al. The triterpenoid sapogenin (2\u03b1-OH-Protopanoxadiol) ameliorates metabolic syndrome via the intestinal FXR\/GLP-1 axis through gut microbiota remodelling. Cell Death Dis. 2020;11(9):770.","journal-title":"Cell Death Dis"},{"key":"1305_CR15","doi-asserted-by":"publisher","first-page":"154595","DOI":"10.1016\/j.phymed.2022.154595","volume":"109","author":"Z Luo","year":"2023","unstructured":"Luo Z, Xu W, Yuan T, et al. Platycodon grandiflorus root extract activates hepatic PI3K\/PIP3\/Akt insulin signaling by enriching gut Akkermansia muciniphila in high fat diet fed mice. Phytomedicine. 2023;109:154595.","journal-title":"Phytomedicine"},{"issue":"5","key":"1305_CR16","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1210\/en.2007-0966","volume":"149","author":"ZL Chu","year":"2008","unstructured":"Chu ZL, Carroll C, Alfonso J, et al. A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release. Endocrinology. 2008;149(5):2038\u201347.","journal-title":"Endocrinology"},{"issue":"1","key":"1305_CR17","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1152\/physrev.00031.2014","volume":"97","author":"RE Steinert","year":"2017","unstructured":"Steinert RE, Feinle-Bisset C, Asarian L, et al. Ghrelin, CCK, GLP-1, and PYY(3\u201336): secretory controls and physiological roles in eating and glycemia in health, obesity, and after RYGB. Physiol Rev. 2017;97(1):411\u201363.","journal-title":"Physiol Rev"},{"issue":"6707","key":"1305_CR18","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1126\/science.adj2537","volume":"385","author":"KS Kim","year":"2024","unstructured":"Kim KS, Park JS, Hwang E, et al. GLP-1 increases preingestive satiation via hypothalamic circuits in mice and humans. Science. 2024;385(6707):438\u201346.","journal-title":"Science"},{"issue":"6","key":"1305_CR19","doi-asserted-by":"publisher","first-page":"111170","DOI":"10.1016\/j.celrep.2022.111170","volume":"40","author":"C Bourouh","year":"2022","unstructured":"Bourouh C, Courty E, Rolland L, et al. The transcription factor E2F1 controls the GLP-1 receptor pathway in pancreatic \u03b2 cells. Cell Rep. 2022;40(6):111170.","journal-title":"Cell Rep"},{"issue":"11","key":"1305_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/nu9111192","volume":"9","author":"LY Wang","year":"2017","unstructured":"Wang LY, Cheng KC, Li Y, et al. The dietary furocoumarin imperatorin increases plasma GLP-1 levels in type 1-like diabetic rats. Nutrients. 2017;9(11):1192.","journal-title":"Nutrients"},{"issue":"16","key":"1305_CR21","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/j.cub.2007.07.046","volume":"17","author":"AN Pronin","year":"2007","unstructured":"Pronin AN, Xu H, Tang H, et al. Specific alleles of bitter receptor genes influence human sensitivity to the bitterness of aloin and saccharin. Curr Biol. 2007;17(16):1403\u20138.","journal-title":"Curr Biol"},{"issue":"2","key":"1305_CR22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.bcp.2015.07.012","volume":"97","author":"Y Yu","year":"2015","unstructured":"Yu Y, Hao G, Zhang Q, et al. Berberine induces GLP-1 secretion through activation of bitter taste receptor pathways. Biochem Pharmacol. 2015;97(2):173\u20137.","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"1305_CR23","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.nut.2010.02.004","volume":"27","author":"DY Kwon","year":"2011","unstructured":"Kwon DY, Hong SM, Ahn IS, et al. Isoflavonoids and peptides from meju, long-term fermented soybeans, increase insulin sensitivity and exert insulinotropic effects in vitro. Nutrition. 2011;27(2):244\u201352.","journal-title":"Nutrition"},{"key":"1305_CR24","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3389\/fphar.2017.00468","volume":"8","author":"A Ladurner","year":"2017","unstructured":"Ladurner A, Zehl M, Grienke U, et al. Allspice and clove as source of triterpene acids activating the G protein-coupled bile acid receptor TGR5. Front Pharmacol. 2017;8:468.","journal-title":"Front Pharmacol"},{"issue":"8","key":"1305_CR25","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1016\/j.apsb.2024.04.027","volume":"14","author":"Z Luo","year":"2024","unstructured":"Luo Z, Zhou W, Xie T, et al. The role of botanical triterpenoids and steroids in bile acid metabolism, transport, and signaling: pharmacological and toxicological implications. Acta Pharm Sin B. 2024;14(8):3385\u2013415.","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"1305_CR26","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1002\/hep.30429","volume":"70","author":"RS Khan","year":"2019","unstructured":"Khan RS, Bril F, Cusi K, et al. Modulation of insulin resistance in nonalcoholic fatty liver disease. Hepatology. 2019;70(2):711\u201324.","journal-title":"Hepatology"},{"issue":"4","key":"1305_CR27","doi-asserted-by":"publisher","first-page":"262","DOI":"10.4093\/dmj.2012.36.4.262","volume":"36","author":"J Lee","year":"2012","unstructured":"Lee J, Hong SW, Rhee EJ, et al. GLP-1 receptor agonist and non-alcoholic fatty liver disease. Diabetes Metab J. 2012;36(4):262\u20137.","journal-title":"Diabetes Metab J"},{"issue":"7","key":"1305_CR28","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.bcp.2009.11.017","volume":"79","author":"Y Yu","year":"2010","unstructured":"Yu Y, Liu L, Wang X, et al. Modulation of glucagon-like peptide-1 release by berberine: in vivo and in vitro studies. Biochem Pharmacol. 2010;79(7):1000\u20136.","journal-title":"Biochem Pharmacol"},{"key":"1305_CR29","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3389\/fphar.2018.00801","volume":"9","author":"M Chu","year":"2018","unstructured":"Chu M, Chen X, Wang J, et al. Polypharmacology of berberine based on multi-target binding motifs. Front Pharmacol. 2018;9:801.","journal-title":"Front Pharmacol"},{"key":"1305_CR30","doi-asserted-by":"publisher","first-page":"1500511","DOI":"10.3389\/fphar.2025.1500511","volume":"16","author":"P Sun","year":"2025","unstructured":"Sun P, Wang Z, Ma Y, et al. Advance in identified targets of berberine. Front Pharmacol. 2025;16:1500511.","journal-title":"Front Pharmacol"},{"issue":"3","key":"1305_CR31","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/ptr.6544","volume":"34","author":"A Mohammed","year":"2020","unstructured":"Mohammed A, Ibrahim MA, Tajuddeen N, et al. Antidiabetic potential of anthraquinones: a review. Phytother Res. 2020;34(3):486\u2013504.","journal-title":"Phytother Res"},{"issue":"41","key":"1305_CR32","doi-asserted-by":"publisher","first-page":"36032","DOI":"10.1074\/jbc.M111.246983","volume":"286","author":"N Singh","year":"2011","unstructured":"Singh N, Pydi SP, Upadhyaya J, et al. Structural basis of activation of bitter taste receptor T2R1 and comparison with class A G-protein-coupled receptors (GPCRs). J Biol Chem. 2011;286(41):36032\u201341.","journal-title":"J Biol Chem"},{"issue":"21","key":"1305_CR33","doi-asserted-by":"publisher","first-page":"11764","DOI":"10.1021\/jf202816u","volume":"59","author":"WS Roland","year":"2011","unstructured":"Roland WS, Vincken JP, Gouka RJ, et al. Soy isoflavones and other isoflavonoids activate the human bitter taste receptors hTAS2R14 and hTAS2R39. J Agric Food Chem. 2011;59(21):11764\u201371.","journal-title":"J Agric Food Chem"},{"issue":"19","key":"1305_CR34","doi-asserted-by":"publisher","first-page":"13452","DOI":"10.1021\/acs.jmedchem.2c01394","volume":"65","author":"C Zhang","year":"2022","unstructured":"Zhang C, Liu Y, Wang Y, et al. Discovery of betulinic acid derivatives as potent intestinal farnesoid X receptor antagonists to ameliorate nonalcoholic steatohepatitis. J Med Chem. 2022;65(19):13452\u201372.","journal-title":"J Med Chem"},{"issue":"10","key":"1305_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13102405","volume":"13","author":"DO Moon","year":"2025","unstructured":"Moon DO. Structure-based insights into TGR5 activation by natural compounds: therapeutic implications and emerging strategies for obesity management. Biomedicines. 2025;13(10):2405.","journal-title":"Biomedicines"},{"issue":"1","key":"1305_CR36","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12964-023-01219-9","volume":"21","author":"D Zhang","year":"2023","unstructured":"Zhang D, Jian YP, Zhang YN, et al. Short-chain fatty acids in diseases. Cell Commun Signal. 2023;21(1):212.","journal-title":"Cell Commun Signal"},{"key":"1305_CR37","doi-asserted-by":"publisher","first-page":"155437","DOI":"10.1016\/j.phymed.2024.155437","volume":"126","author":"Y Liu","year":"2024","unstructured":"Liu Y, Sun Z, Dong R, et al. Rutin ameliorated lipid metabolism dysfunction of diabetic NAFLD via AMPK\/SREBP1 pathway. Phytomedicine. 2024;126:155437.","journal-title":"Phytomedicine"},{"issue":"13","key":"1305_CR38","doi-asserted-by":"publisher","first-page":"e33704","DOI":"10.1016\/j.heliyon.2024.e33704","volume":"10","author":"X Chen","year":"2024","unstructured":"Chen X, Mei XY, Ren ZM, et al. Comprehensive insights into berberine\u2019s hypoglycemic mechanisms: a focus on ileocecal microbiome in db\/db mice. Heliyon. 2024;10(13):e33704.","journal-title":"Heliyon"},{"issue":"18","key":"1305_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28186501","volume":"28","author":"Q Hu","year":"2023","unstructured":"Hu Q, Hou S, Xiong B, et al. Therapeutic effects of baicalin on diseases related to gut-brain axis dysfunctions. Molecules. 2023;28(18):6501.","journal-title":"Molecules"},{"key":"1305_CR40","doi-asserted-by":"publisher","first-page":"107452","DOI":"10.1016\/j.phrs.2024.107452","volume":"209","author":"H Mansour","year":"2024","unstructured":"Mansour H, Slika H, Nasser SA, et al. Flavonoids, gut microbiota and cardiovascular disease: dynamics and interplay. Pharmacol Res. 2024;209:107452.","journal-title":"Pharmacol Res"},{"issue":"1","key":"1305_CR41","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s41467-025-55845-7","volume":"16","author":"Z Qu","year":"2025","unstructured":"Qu Z, Liu H, Yang J, et al. Selective utilization of medicinal polysaccharides by human gut Bacteroides and Parabacteroides species. Nat Commun. 2025;16(1):638.","journal-title":"Nat Commun"},{"issue":"23","key":"1305_CR42","doi-asserted-by":"publisher","first-page":"10401","DOI":"10.1039\/D3FO04051H","volume":"14","author":"J Shen","year":"2023","unstructured":"Shen J, Wang S, Xia H, et al. Akkermansia muciniphila attenuated lipopolysaccharide-induced acute lung injury by modulating the gut microbiota and SCFAs in mice. Food Funct. 2023;14(23):10401\u201317.","journal-title":"Food Funct"},{"key":"1305_CR43","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.2147\/JIR.S352863","volume":"15","author":"J Peng","year":"2022","unstructured":"Peng J, Li X, Zheng L, et al. Ban-Lan-Gen granule alleviates dextran sulfate sodium-induced chronic relapsing colitis in mice via regulating gut microbiota and restoring gut SCFA derived-GLP-1 production. J Inflamm Res. 2022;15:1457\u201370.","journal-title":"J Inflamm Res"},{"issue":"1","key":"1305_CR44","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s40168-021-01115-9","volume":"9","author":"Z Wu","year":"2021","unstructured":"Wu Z, Huang S, Li T, et al. Gut microbiota from green tea polyphenol-dosed mice improves intestinal epithelial homeostasis and ameliorates experimental colitis. Microbiome. 2021;9(1):184.","journal-title":"Microbiome"},{"issue":"16","key":"1305_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/nu16162660","volume":"16","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Chen B, Zhang X, et al. Exploration of the Muribaculaceae family in the gut microbiota: diversity, metabolism, and function. Nutrients. 2024;16(16):2660.","journal-title":"Nutrients"},{"issue":"1","key":"1305_CR46","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40168-019-0637-2","volume":"7","author":"I Lagkouvardos","year":"2019","unstructured":"Lagkouvardos I, Lesker TR, Hitch TCA, et al. Sequence and cultivation study of Muribaculaceae reveals novel species, host preference, and functional potential of this yet undescribed family. Microbiome. 2019;7(1):28.","journal-title":"Microbiome"},{"issue":"1","key":"1305_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1832857","volume":"12","author":"L Ma","year":"2020","unstructured":"Ma L, Ni Y, Wang Z, et al. Spermidine improves gut barrier integrity and gut microbiota function in diet-induced obese mice. Gut Microbes. 2020;12(1):1\u201319.","journal-title":"Gut Microbes"},{"issue":"3","key":"1305_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11030685","volume":"11","author":"T Baur","year":"2023","unstructured":"Baur T, D\u00fcrre P. New insights into the physiology of the propionate producers Anaerotignum propionicum and Anaerotignum neopropionicum (formerly Clostridium propionicum and Clostridium neopropionicum). Microorganisms. 2023;11(3):685.","journal-title":"Microorganisms"},{"key":"1305_CR49","doi-asserted-by":"publisher","first-page":"1103836","DOI":"10.3389\/fmicb.2022.1103836","volume":"13","author":"V Singh","year":"2022","unstructured":"Singh V, Lee G, Son H, et al. Butyrate producers, \u201cthe sentinel of gut\u201d: their intestinal significance with and beyond butyrate, and prospective use as microbial therapeutics. Front Microbiol. 2022;13:1103836.","journal-title":"Front Microbiol"},{"key":"1305_CR50","doi-asserted-by":"publisher","first-page":"154217","DOI":"10.1016\/j.phymed.2022.154217","volume":"102","author":"S Yan","year":"2022","unstructured":"Yan S, Chang J, Hao X, et al. Berberine regulates short-chain fatty acid metabolism and alleviates the colitis-associated colorectal tumorigenesis through remodeling intestinal flora. Phytomedicine. 2022;102:154217.","journal-title":"Phytomedicine"},{"issue":"6","key":"1305_CR51","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.gpb.2019.09.007","volume":"18","author":"X Xu","year":"2020","unstructured":"Xu X, Gao Z, Yang F, et al. Antidiabetic effects of Gegen Qinlian Decoction via the gut microbiota are attributable to its key ingredient Berberine. Genomics Proteomics Bioinform. 2020;18(6):721\u201336.","journal-title":"Genomics Proteomics Bioinform"},{"key":"1305_CR52","doi-asserted-by":"publisher","first-page":"110923","DOI":"10.1016\/j.biopha.2020.110923","volume":"132","author":"B Li","year":"2020","unstructured":"Li B, Liu M, Wang Y, et al. Puerarin improves the bone micro-environment to inhibit OVX-induced osteoporosis via modulating SCFAs released by the gut microbiota and repairing intestinal mucosal integrity. Biomed Pharmacother. 2020;132:110923.","journal-title":"Biomed Pharmacother"},{"issue":"13","key":"1305_CR53","doi-asserted-by":"publisher","first-page":"7928","DOI":"10.1002\/jsfa.13624","volume":"104","author":"J Su","year":"2024","unstructured":"Su J, Dai Y, Wu X, et al. Maslinic acid alleviates alcoholic liver injury in mice and regulates intestinal microbiota via the gut-liver axis. J Sci Food Agric. 2024;104(13):7928\u201338.","journal-title":"J Sci Food Agric"},{"issue":"6380","key":"1305_CR54","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1126\/science.aao5774","volume":"359","author":"L Zhao","year":"2018","unstructured":"Zhao L, Zhang F, Ding X, et al. Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science (New York, NY). 2018;359(6380):1151\u20136.","journal-title":"Science (New York, NY)"},{"issue":"1","key":"1305_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00535-016-1242-9","volume":"52","author":"M Sun","year":"2017","unstructured":"Sun M, Wu W, Liu Z, et al. Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases. J Gastroenterol. 2017;52(1):1\u20138.","journal-title":"J Gastroenterol"},{"issue":"2","key":"1305_CR56","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1210\/endrev\/bnaa032","volume":"42","author":"BA Mclean","year":"2021","unstructured":"Mclean BA, Wong CK, Campbell JE, et al. Revisiting the complexity of GLP-1 action from sites of synthesis to receptor activation. Endocr Rev. 2021;42(2):101\u201332.","journal-title":"Endocr Rev"},{"issue":"2","key":"1305_CR57","doi-asserted-by":"publisher","first-page":"364","DOI":"10.2337\/db11-1019","volume":"61","author":"G Tolhurst","year":"2012","unstructured":"Tolhurst G, Heffron H, Lam YS, et al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes. 2012;61(2):364\u201371.","journal-title":"Diabetes"},{"issue":"Pt B","key":"1305_CR58","doi-asserted-by":"publisher","first-page":"117050","DOI":"10.1016\/j.jep.2023.117050","volume":"318","author":"X Wang","year":"2024","unstructured":"Wang X, Liang F, Dai Z, et al. Combination of Coptis chinensis polysaccharides and berberine ameliorates ulcerative colitis by regulating gut microbiota and activating AhR\/IL-22 pathway. J Ethnopharmacol. 2024;318(Pt B):117050.","journal-title":"J Ethnopharmacol"},{"key":"1305_CR59","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jot.2022.08.009","volume":"35","author":"W Yang","year":"2022","unstructured":"Yang W, Gao B, Qin L, et al. Puerarin improves skeletal muscle strength by regulating gut microbiota in young adult rats. J Orthop Translat. 2022;35:87\u201398.","journal-title":"J Orthop Translat"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-025-01305-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-025-01305-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-025-01305-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T07:02:08Z","timestamp":1769238128000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13020-025-01305-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,24]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1305"],"URL":"https:\/\/doi.org\/10.1186\/s13020-025-01305-9","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,24]]},"assertion":[{"value":"24 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were conducted following approval from the Institutional Animal Care and Use Committee of Nanjing University of Chinese Medicine (permit NO. 202307A059) and in accordance with the guidelines outlined by the National Institutes of Health for the use of experimental animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}